Indivior settles class action lawsuit for $30M over alleged suppression of generic competition for Suboxone
2 years ago
24
Indivior reached a $30M settlement to resolve a class action lawsuit filed by health plans that accuses the company of unlawfully stifling competition for its opioid treatment Suboxone.